Mutational heterogeneity in human cancers: origin and consequences.

Cancer recapitulates Darwinian evolution. Mutations acquired during life that provide cells with a growth or survival advantage will preferentially multiply to form a tumor. As a result of The Cancer Genome Atlas Project, we have gathered detailed information on the nucleotide sequence changes in a number of human cancers. The sources of mutations in cancer are diverse, and the complexity of those found to be clonally present in tumors has increasingly made it difficult to identify key rate-limiting genes for tumor growth that could serve as potential targets for directed therapies. The impact of DNA sequencing on future cancer research and personalized therapy is likely to be profound and merits critical evaluation.

[1]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[2]  R. Beckman.  Mutator Mutations Enhance Tumorigenic Efficiency across Fitness Landscapes , 2009, PloS one.

[3]  D. Louis,et al.  Faculty Opinions recommendation of Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. , 2009 .

[4]  Kun-Liang Guan,et al.  Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.

[5]  J. Stamatoyannopoulos,et al.  Human mutation rate associated with DNA replication timing , 2009, Nature Genetics.

[6]  M. Bronner,et al.  Genomic biomarkers to improve ulcerative colitis neoplasia surveillance. , 2008, The American journal of pathology.

[7]  P. Hanawalt,et al.  Transcription-coupled DNA repair: two decades of progress and surprises , 2008, Nature Reviews Molecular Cell Biology.

[8]  Andrey Korshunov,et al.  Analysis of the IDH1 codon 132 mutation in brain tumors , 2008, Acta Neuropathologica.

[9]  G. Parmigiani,et al.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers , 2008, Proceedings of the National Academy of Sciences.

[10]  Amy E. Hawkins,et al.  DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.

[11]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[12]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[13]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[14]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[15]  M. Stratton,et al.  Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing , 2008, Proceedings of the National Academy of Sciences.

[16]  C. Harris,et al.  Advances in chemical carcinogenesis: a historical review and prospective. , 2008, Cancer research.

[17]  L. Loeb,et al.  DNA polymerases and human disease , 2008, Nature Reviews Genetics.

[18]  N. Wright,et al.  Colonic crypt organization and tumorigenesis , 2008, Nature Reviews Cancer.

[19]  Antony V. Cox,et al.  Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing , 2008, Nature Genetics.

[20]  Robert A Beckman,et al.  Genetic instability is not a requirement for tumor development. , 2008, Cancer research.

[21]  Robert A Beckman,et al.  Cancers exhibit a mutator phenotype: clinical implications. , 2008, Cancer research.

[22]  A. Ullrich,et al.  Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.

[23]  Rakesh Nagarajan,et al.  Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. , 2008, Blood.

[24]  Martin A. Nowak,et al.  Comparative lesion sequencing provides insights into tumor evolution , 2008, Proceedings of the National Academy of Sciences.

[25]  Sam W. Lee,et al.  Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes. , 2008, Cancer research.

[26]  K. Kinzler,et al.  Epitope landscape in breast and colorectal cancer. , 2008, Cancer research.

[27]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[28]  S. Fröhling,et al.  High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia. , 2007, Blood.

[29]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[30]  Carlo C. Maley,et al.  Animal Cell Differentiation Patterns Suppress Somatic Evolution , 2007, PLoS Comput. Biol..

[31]  Giovanni Parmigiani,et al.  Response to Comments on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.

[32]  Guy Cavet,et al.  Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.

[33]  Shenghui He,et al.  Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU , 2007, Nature.

[34]  Martin A. Nowak,et al.  Genetic Progression and the Waiting Time to Cancer , 2007, PLoS Comput. Biol..

[35]  D. Lin,et al.  Fen1 mutations result in autoimmunity, chronic inflammation and cancers , 2007, Nature Medicine.

[36]  S. Nakajima,et al.  Werner syndrome protein interacts functionally with translesion DNA polymerases , 2007, Proceedings of the National Academy of Sciences.

[37]  C. Maley,et al.  Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array‐CGH , 2007, Genes, chromosomes & cancer.

[38]  G. Prindull,et al.  Are postnatal hemangioblasts generated by dedifferentiation from committed hematopoietic stem cells? , 2007, Experimental hematology.

[39]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[40]  W. Gerald,et al.  A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies , 2006, PLoS medicine.

[41]  C. Maley,et al.  Cancer as an evolutionary and ecological process , 2006, Nature Reviews Cancer.

[42]  Lawrence D True,et al.  Human cancers express a mutator phenotype , 2006, Proceedings of the National Academy of Sciences.

[43]  J. Cairns,et al.  Anecdotal, Historical and Critical Commentaries on Genetics : Paradox Found , 1987 .

[44]  L. Loeb,et al.  Efficiency of carcinogenesis with and without a mutator mutation , 2006, Proceedings of the National Academy of Sciences.

[45]  P. Hanawalt,et al.  DNA repair: from molecular mechanism to human disease. , 2006, DNA repair.

[46]  Susan O'Brien,et al.  Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. , 2006, The New England journal of medicine.

[47]  S. Nishimura.  8-Hydroxyguanine: From its discovery in 1983 to the present status , 2006, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[48]  Hongyue Dai,et al.  Gene expression changes associated with progression and response in chronic myeloid leukemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Richard Lugg,et al.  Sequence analysis of the protein kinase gene family in human testicular germ‐cell tumors of adolescents and adults , 2006, Genes, chromosomes & cancer.

[50]  L. Loeb,et al.  Negative Clonal Selection in Tumor Evolution , 2005, Genetics.

[51]  Andrew D. Yates,et al.  Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.

[52]  Martin A. Nowak,et al.  Dynamics of chronic myeloid leukaemia , 2005, Nature.

[53]  Andrew D. Yates,et al.  A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.

[54]  J. Bielas,et al.  Quantification of random genomic mutations , 2005, Nature Methods.

[55]  R. Weinberg,et al.  Species- and cell type-specific requirements for cellular transformation. , 2004, Cancer cell.

[56]  B. Druker.  Imatinib: Paradigm or Anomaly? , 2004, Cell cycle.

[57]  Giovanni Parmigiani,et al.  Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.

[58]  E. Luebeck,et al.  Multistage carcinogenesis and the incidence of human cancer , 2003, Genes, chromosomes & cancer.

[59]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.

[60]  Jason H Bielas,et al.  Elevated mutagenesis and decreased DNA repair at a transgene are associated with proliferation but not apoptosis in p53-deficient cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Golub.  Mining the genome for combination therapies , 2003, Nature Medicine.

[62]  K. Loeb,et al.  Multiple mutations and cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[64]  P. Hanawalt,et al.  Ultraviolet-sensitive syndrome cells are defective in transcription-coupled repair of cyclobutane pyrimidine dimers. , 2002, DNA repair.

[65]  J. Coxhead,et al.  Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Stringer,et al.  Embryonic stem cells and somatic cells differ in mutation frequency and type , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Giovanni Parmigiani,et al.  Prevalence of somatic alterations in the colorectal cancer cell genome , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Alison L. Livingston,et al.  Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.

[69]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[70]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[71]  T. Lindahl,et al.  Quality control by DNA repair. , 1999, Science.

[72]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[73]  P. Jeggo,et al.  Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient , 1999, Current Biology.

[74]  F. Hanaoka,et al.  Xeroderma pigmentosum variant (XP‐V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity , 1999, The EMBO journal.

[75]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[76]  M. Speicher,et al.  Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[77]  G. Marsischky,et al.  Eukaryotic DNA mismatch repair. , 1999, Current opinion in genetics & development.

[78]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[79]  S. Knuutila,et al.  DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. , 1998, The American journal of pathology.

[80]  C. Griffin,et al.  Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization. , 1998, Cancer research.

[81]  A. Jackson,et al.  The mutation rate and cancer. , 1998, Genetics.

[82]  D. Birnbaum,et al.  Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas. , 1997, Cancer research.

[83]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[84]  M. Chung,et al.  Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. , 1996, Cancer research.

[85]  N. Ellis,et al.  The Bloom's syndrome gene product is homologous to RecQ helicases , 1995, Cell.

[86]  G. Merlino,et al.  Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. , 1994, The American journal of pathology.

[87]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[88]  T. Petes,et al.  Instability of simple sequence repeats in a mammalian cell line. , 1994, Human molecular genetics.

[89]  L. Loeb,et al.  Oxygen radical induced mutagenesis is DNA polymerase specific. , 1994, Journal of molecular biology.

[90]  C. Harris,et al.  p53: at the crossroads of molecular carcinogenesis and risk assessment. , 1993, Science.

[91]  R. Floyd.  Measurement of oxidative stress in vivo , 1993 .

[92]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[93]  M. Boehnke,et al.  Estimation of mutation rates based on the analysis of polypeptide constituents of cultured human lymphoblastoid cells. , 1988, Genetics.

[94]  M. Goodman,et al.  Comparison of nucleotide interactions in water, proteins, and vacuum: model for DNA polymerase fidelity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[95]  K E Warner,et al.  Smoking and lung cancer: an overview. , 1984, Cancer research.

[96]  T. Kunkel,et al.  Depurination-induced infidelity of deoxyribonucleic acid synthesis with purified deoxyribonucleic acid replication proteins in vitro. , 1983, Biochemistry.

[97]  P. Nowell.  The clonal evolution of tumor cell populations. , 1976, Science.

[98]  I. Lehman,et al.  Biochemical characterization of mutant forms of DNA polymerase I from Escherichia coli. I. The polA12 mutation. , 1976, The Journal of biological chemistry.

[99]  John Cairns,et al.  Mutation selection and the natural history of cancer , 1975, Nature.

[100]  L. Loeb,et al.  Errors in DNA replication as a basis of malignant changes. , 1974, Cancer research.

[101]  P. Rous.  Transmission of a malignant new growth by means of a cell-free filtrate. , 1973, Connecticut medicine.

[102]  B. Ames,et al.  Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[103]  J. Cleaver.  Defective Repair Replication of DNA in Xeroderma Pigmentosum , 1968, Nature.

[104]  A. George.  The metabolic basis of inherited disease , 1961 .

[105]  R. Prehn,et al.  Immunity to methylcholanthrene-induced sarcomas. , 1957, Journal of the National Cancer Institute.

[106]  P. Armitage,et al.  The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis , 1954, British Journal of Cancer.

[107]  E. A. Graham,et al.  Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. , 1950, Bulletin of the World Health Organization.

[108]  E. A. Graham,et al.  Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. , 1950, Journal of the American Medical Association.

[109]  J. Robson,et al.  Chemical Production of Mutations , 1946, Nature.

[110]  Reinhard Wolf,et al.  Coding-Sequence Determinants of Gene Expression in Escherichia coli , 2009 .

[111]  F. Ducray,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[112]  A. Levine,et al.  The First Twenty-Five Years of p53 Research , 2007 .

[113]  A. Knudson.  Hereditary cancer: Two hits revisited , 2005, Journal of Cancer Research and Clinical Oncology.

[114]  E. Hecker.  Phorbol esters from croton oil chemical nature and biological activities , 2004, The Science of Nature.

[115]  Robert DeMars,et al.  The spontaneous azaguanine-resistant mutants of diploid human fibroblasts , 2004, Humangenetik.

[116]  Giovanni Parmigiani,et al.  Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers , 2003, Nature Reviews Cancer.

[117]  P. Modrich,et al.  Mismatch repair in replication fidelity, genetic recombination, and cancer biology. , 1996, Annual review of biochemistry.

[118]  A. Balmain,et al.  How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .

[119]  N. Fausto,et al.  Mechanisms of growth regulation in liver regeneration and hepatic carcinogenesis. , 1993, Progress in liver diseases.

[120]  R. Albertini,et al.  In vivo somatic mutations in humans: measurement and analysis. , 1990, Annual review of genetics.

[121]  L. Loeb,et al.  Chapter 15 - KINETIC AND MAGNETIC RESONANCE STUDIES OF THE INTERACTION OF Mn 2+ , SUBSTRATES AND TEMPLATES WITH DNA POLYMERASES , 1986 .

[122]  P. Nowell,et al.  Karyotypic evolution in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.

[123]  F. Wedler,et al.  Manganese in metabolism and enzyme function , 1986 .

[124]  H. Varmus,et al.  Synthesis, structure, and integration of the DNA of RNA tumor viruses. , 1979, Cold Spring Harbor symposia on quantitative biology.